HUP9900354A3 - Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation - Google Patents

Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation

Info

Publication number
HUP9900354A3
HUP9900354A3 HU9900354A HUP9900354A HUP9900354A3 HU P9900354 A3 HUP9900354 A3 HU P9900354A3 HU 9900354 A HU9900354 A HU 9900354A HU P9900354 A HUP9900354 A HU P9900354A HU P9900354 A3 HUP9900354 A3 HU P9900354A3
Authority
HU
Hungary
Prior art keywords
lipide
peroxidation
condensed
inhibition
preparation
Prior art date
Application number
HU9900354A
Other languages
Hungarian (hu)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU9900354A priority Critical patent/HUP9900354A3/en
Publication of HU9900354D0 publication Critical patent/HU9900354D0/en
Priority to AU28194/00A priority patent/AU2819400A/en
Priority to PCT/HU2000/000011 priority patent/WO2000053166A2/en
Publication of HUP9900354A2 publication Critical patent/HUP9900354A2/en
Publication of HUP9900354A3 publication Critical patent/HUP9900354A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
HU9900354A 1999-02-15 1999-02-15 Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation HUP9900354A3 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU9900354A HUP9900354A3 (en) 1999-02-15 1999-02-15 Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation
AU28194/00A AU2819400A (en) 1999-02-15 2000-02-15 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation
PCT/HU2000/000011 WO2000053166A2 (en) 1999-02-15 2000-02-15 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9900354A HUP9900354A3 (en) 1999-02-15 1999-02-15 Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation

Publications (3)

Publication Number Publication Date
HU9900354D0 HU9900354D0 (en) 1999-04-28
HUP9900354A2 HUP9900354A2 (en) 2001-01-29
HUP9900354A3 true HUP9900354A3 (en) 2001-02-28

Family

ID=89997786

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900354A HUP9900354A3 (en) 1999-02-15 1999-02-15 Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation

Country Status (3)

Country Link
AU (1) AU2819400A (en)
HU (1) HUP9900354A3 (en)
WO (1) WO2000053166A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201536795A (en) 2013-05-31 2015-10-01 Medeia Therapeutics Ltd Use of arylthiazine compounds as cytoprotectants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639751A (en) * 1990-12-21 1997-06-17 Cyogyszerkutato Intezet Kft N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
US5519019A (en) * 1990-12-21 1996-05-21 Gyogyszerkutato Intezet N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same
US6172043B1 (en) * 1997-01-10 2001-01-09 Massachusetts Institute Of Technology Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides
UA67749C2 (en) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]benzodiazepine being inhibitors of the ampa/kainite receptor
WO1999007708A1 (en) * 1997-08-12 1999-02-18 EGIS Gyógyszergyár Rt. 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors

Also Published As

Publication number Publication date
HUP9900354A2 (en) 2001-01-29
AU2819400A (en) 2000-09-28
HU9900354D0 (en) 1999-04-28
WO2000053166A2 (en) 2000-09-14
WO2000053166A3 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUP9901807A3 (en) Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
EE04613B1 (en) Carbohydrate-substituted 1,4-benzothiazepine-1,1-dioxide derivatives, process for their preparation, use of the compounds and medicament containing them
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HK1059215A1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
HUP0104867A3 (en) Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
HUP9801256A3 (en) 5'-deoxy-cytidine derivatives, preparation and use thereof and pharmaceutical compositions
EE9900162A (en) Method of preventing breast cancer, pharmaceutical preparation and product, and use of the active ingredient
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
AR013264A1 (en) DERIVATIVES OF 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5-B] INDOL-1-ACETAMIDA, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
AU1546101A (en) Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders
HUP9901680A3 (en) Use of piperazin-, piperidin- or hexahidropiridazin derivatives for the preparation of pharmaceutical compositions, new piperazin derivatives and pharmaceutical compositions containing these compounds
HUP0105426A3 (en) Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems and pharmaceutical compositions thereof
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock